RxDoctor Payments Data

Connie Fiser, APRN

Adult Health · Flint, TXNPI 1326654724

Payments from drug & device makers

$2,927in general payments, 2019–2025

Across 28 payments — averaging $104.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$338
  • Teva Pharmaceuticals USA, Inc.$326
  • Boehringer Ingelheim$302
  • Axonics, Inc.$279
  • Madrigal Pharmaceuticals$254
  • Sanofi-aventis U.S. LLC$235
  • plus $1K from 13 others

What the payments were for

  • Food & beverage$2,927100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,927 in reported general payments places this provider in the 80th percentile of 933 adult health providers in Texas.

See all adult health providers in Texas

Medicare billing

Part B allowed, 2024
$40,026
Medicare patients
72
Services billed
532

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban29$20,583
LinzessLinaclotide11$5,830
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$1,059
Gabapentin36$500
Duloxetine Hcl16$305
Buspirone Hcl32$302
Omeprazole18$252
Potassium Chloride35$211
Amlodipine Besylate25$147
Pantoprazole Sodium26$135
Famotidine11$134
Tamsulosin Hcl18$134
Acetaminophen-CodeineAcetaminophen With Codeine11$131
Torsemide16$123
Losartan Potassium17$117

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$124$5,83011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 933 adult health providers in Texas.

Other adult health in Flint

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →